BriaCell Therapeutics Corp (BCT) Stock Price, News, Quotes-Moomoo

CA Stock MarketDetailed Quotes

BCT BriaCell Therapeutics Corp

Watchlist

0.950
0.0000.00%

15min DelayMarket Closed Dec 13 16:00 ET

34.50MMarket Cap-2.38P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

BriaCell Therapeutics Raises $5.55 Million in an Underwritten Offering of Share Units
MT Newswires16:31 ET
Briacell Therapeutics Highlights The Infiltration Of Cancer Fighting Immune Cells Into Tumors, Using CD8 ImmunoPET Imaging Technology, In Its Poster Presentation At 2024 San Antonio Breast Cancer Symposium
BenzingaDec 13 07:52 ET
BriaCell 2024 SABCS Poster Highlights Ability of Bria-IMT Regimen to Increase Cancer-Fighting Immune Cells in Metastatic Breast Cancer
GlobeNewswireDec 13 07:50 ET
Why BriaCell Therapeutics (BCTX) Stock Is Down 40%
BenzingaDec 12 14:33 ET
Promising Phase 2 Results and Safety Profile Justify Buy Rating for BriaCell Therapeutics
TipRanksDec 12 06:26 ET · Ratings
Why DBV Technologies Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket
BenzingaDec 12 05:41 ET

Comments

Stock Region

Jul 19 19:22

Therapeutics Company Reports Major Progression In Its Phase 2 Study Battling Cancer

BriaCell Quadruples Progression-Free Survival in Metastatic Breast Cancer Patient.
The field of oncology has witnessed numerous advancements over the years, yet metastatic breast cancer continues to pose challenges. However, recent developments reported by BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) offer a glimmer of hope. The clinical-stage biotechnology company, known for its innovative immunot...